Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, June 2005, p. 713-721, Vol. 12, No. 6
1071-412X/05/$08.00+0 doi:10.1128/CDLI.12.6.713-721.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702,1 National Institutes of Health, Bethesda, Maryland 20892,2 Camber Corporation/USAMRIID, Fort Detrick, Maryland 21702,3 Goldbelt-Raven/USAMRIID, Fort Detrick, Maryland 21702,4 Centers for Disease Control and Prevention, Atlanta, Georgia 303335
Received 29 January 2005/ Returned for modification 15 February 2005/ Accepted 28 March 2005
Recipients of licensed anthrax vaccine (AVA; Biothrax) could serve as a source of hyperimmune plasma and immunoglobulin for therapy and prophylaxis. We measured serum antibodies during serial weekly to biweekly plasmapheresis in 38 individuals previously vaccinated with 4 to 27 doses of AVA. Immunoglobulin G (IgG) to protective antigen (PA) and toxin neutralization assay (TNA) antibody levels were highly correlated (r = 0.86930 and P < 0.0001 for anti-PA concentration versus TNA concentration). Significant decreases in antibody titer and concentration were observed over time when compared for the number of days from the last AVA injection (P < 0.0001 for both anti-PA and TNA concentration) and for the number of days from the first plasmapheresis (P = 0.0007 for anti-PA concentration and P = 0.0025 for TNA concentration). The rate of the decrease in total IgG concentration (half-life [t1/2] = 198.90 days after first plasmapheresis) was significantly less than the decrease in anti-PA IgG (t1/2 = 63.53 days) (P < 0.0001), indicating that the reduction in anti-PA IgG was more likely due to natural decay than plasmapheresis. The time since the last injection and the time after initial plasmapheresis are important elements in considering an optimal schedule for collecting anthrax hyperimmune plasma. Good correlation between IgG to PA and TNA antibodies suggests that the anti-PA enzyme-linked immunosorbent assay can be used as a high-throughput screen for functional immune reactivity in donor plasma units.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»